DR.Chip Biotechnology Incorporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 21.06 million compared to TWD 18.4 million a year ago. Net loss was TWD 8.28 million compared to TWD 4.44 million a year ago. Basic loss per share was TWD 0.44 compared to TWD 0.2288 a year ago. Diluted loss per share was TWD 0.44 compared to TWD 0.2288 a year ago.
For the nine months, sales was TWD 61.39 million compared to TWD 62.67 million a year ago. Net loss was TWD 22.15 million compared to TWD 10.63 million a year ago. Basic loss per share was TWD 1.17 compared to TWD 0.5592 a year ago. Diluted loss per share was TWD 1.17 compared to TWD 0.5592 a year ago.